• Explore /
  • Poster
  • / Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors.

Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors.

Abstract Poster

Authors

null

Kaysia Ludford

The University of Texas MD Anderson, Houston, TX

Kaysia Ludford , Kanwal Pratap Singh Raghav , Mariela A. Blum Murphy , Nicole D. Fleming , Douglas A. Nelson , Michael Sangmin Lee , Brandon George Smaglo , Y. Nancy You , Matthew Murray Tillman , Carlos Kamiya-Matsuoka , Selvi Thirumurthi , Craig Messick , Benny Johnson , Eduardo Vilar Sanchez , Arvind Dasari , Jane V Thomas , Wai Chin Foo , Wei Qiao , Scott Kopetz , Michael J. Overman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

PD1/PD-L1 Inhibitor Monotherapy

Clinical Trial Registration Number

NCT04082572

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2520)

DOI

10.1200/JCO.2021.39.15_suppl.2520

Abstract #

2520

Abstract Disclosures

Similar Posters

First Author: Panpan Zhang

First Author: Tomoko Jogo

First Author: Daniel Olson

First Author: Aung Naing